CRADS Calculator v. 2023

ACR's CT Colonography Imaging Reporting & Data System (C-RADS ™), for describing colorectal and extra-colonic findings - Version 2023 (released January 2024)

C-RADS

Colonic findings

Is any of the following true about this study?

C0 = Inadequate Study

Repeat CTC or consider an alternative screening test if inadequate.

C0 = Awaiting prior comparisons

Amend when prior studies are available.
Which abnormalities have you identified? (select all that apply)

C1 = Normal Colon or Benign Lesion

Recommendation: Continue routine screening every 5-10 years

C2a = Intermediate Polyp or Indeterminate Finding

Recommendation: Repeat CTC in 3y or colonoscopy. For polyps 6 mm and greater, recommend polypectomy in suitable patients versus follow-up study in 3 years, subject to individual patient circumstance.

C2b = Likely benign diverticular finding

Likely benign: recommend repeat CTC in 5 y
Uncertain benign: recommend repeat CTC in ≤3 y

C3 = Polyp, Possibly Advanced Adenoma

Recommendation: Colonoscopy
Communicate to referring physician as per accepted guidelines for communication, such as American College of Radiology Practice Parameter for Communication of Diagnostic Imaging Findings. Subject to local practice, endoscopic biopsy may be indicated.

C4 = Likely Malignant Colonic Mass

Recommendation: Surgical and/or oncologic consultation.
Communicate to referring physician as per accepted guidelines for communication, such as American College of Radiology Practice Parameter for Communication of Diagnostic Imaging Findings. Subject to local practice, endoscopic biopsy may be indicated.

Extra-colonic findings

Which of the following applies to the current exam?

E0

Incidence rate of 3%

E1/E2

Incidence rate of 86-88%
No additional workup is indicated

E3

Incidence rate of 4-16%
Further workup may be warranted

E4

Incidence rate of 2-8%
Further workup needed
The scoring of extracolonic findings per C-RADS is very straightforward. Please refer to the following table:

E0 = Limited examCompromised by artifact; evaluation of extracolonic soft tissues is severely limited.No recommendations.
E1 = Normal exam or anatomic variantNo extracolonic abnormalities visible.
Anatomic Variant: eg, retroaortic left renal vein
No recommendations.
E2 = Clinically unimportant findingExamples:
a. Liver, Kidney: simple cysts
b. Gallbladder: cholelithiasis without cholecystitis
c. Vertebra: hemangioma
No work-up indicated.
E3 = Likely unimportant finding or incompletely characterizedExamples:
a. Kidney: minimally complex or homogeneously hyperattenuating cyst
Subject to local practice and patient preference,
work-up may be indicated.
E4 = Potentially important findingExamples:

a. Kidney: solid renal mass
b. Lymphadenopathy
c. Vasculature: aortic aneurysm
d. Lung: non-uniformly calcified parenchymal nodule ≥1 cm

Communicate to referring physician as per accepted practice guidelines.

Related Calculators:

More About the CRADS Calculator

The CT Colonography Reporting and Data System (C‑RADS®), endorsed by the American College of Radiology (ACR), is a standardized framework designed to streamline the classification of findings from CT colonography (CTC). Since its initial release in 2005, C‑RADS has been instrumental in enhancing consistency, clarity, and clinical decision-making for both colonic and extracolonic observations. The 2023 update brings important refinements to the system, further optimizing its utility for radiologists and referring clinicians.

Key Updates in the 2023 C‑RADS Version

  • Introduction of C2b Subcategory: This new classification identifies mass-like diverticular strictures that visually resemble polyps but are commonly benign. This differentiation helps minimize unnecessary colonoscopies.
  • Extracolonic Category Consolidation: E1 and E2 have been merged into a unified E1/E2 category, reflecting the clinical understanding that neither warrants additional imaging or follow-up.

C‑RADS® Colon Categories and Recommended Actions

  • C0: Incomplete or technically inadequate CTC — repeat imaging is recommended.
  • C1: Normal colon or findings considered unequivocally benign — standard interval screening applies.
  • C2a: Indeterminate 6–9 mm polyps — recommend either short-term follow-up CTC or colonoscopy.
  • C2b: Mass-like but likely benign strictures — further evaluation with targeted follow-up may be appropriate.
  • C3: Lesions suggestive of advanced adenomas — diagnostic colonoscopy advised.
  • C4: Highly suspicious findings, such as masses — urgent colonoscopy and further management warranted.

Extracolonic Findings Classification

Extracolonic observations are sorted into categories based on their clinical relevance. E1/E2 covers benign or incidental findings that typically require no further evaluation. In contrast, E3 includes potentially significant anomalies, and E4 reflects findings that may require prompt investigation due to possible serious implications.

Clinical Benefits and Workflow Efficiency

  • Standardized Reporting: Adherence to ACR-approved guidelines enhances clarity and reduces subjective variability in radiology reports [1].
  • Optimized Patient Care: Structured classifications help avoid unnecessary invasive testing and guide appropriate follow-up pathways.
  • Risk Stratification: Differentiation between benign, indeterminate, and high-risk lesions supports better shared decision-making.
  • Data Uniformity: The system’s consistent language facilitates quality assurance, research standardization, and benchmarking efforts [2].

How to Use the CRADS 2023 Calculator

The calculator allows radiologists to input polyp size, location, morphology, and extracolonic findings to automatically generate the appropriate C‑RADS category. The output includes:

  • Category assignment aligned with 2023 ACR recommendations
  • Built-in follow-up suggestions, such as surveillance timelines for C2a lesions
  • Templates for inclusion in radiology reports or EMR documentation

Conclusion

The C‑RADS® 2023 update introduces strategic refinements that improve diagnostic precision and enhance communication among multidisciplinary teams. With simplified extracolonic categories and a new polyp subcategory, the updated system helps radiologists offer patient-centered, evidence-based care while minimizing ambiguity in colorectal cancer screening protocols.

Share your thoughts

Your email address will not be published. Required fields are marked *